Medicare Compliance & Reimbursement
Senators Want Drugmakers To Grant Them More Info
Baucus, Grassley asking questions about 'educational grants.' Senators Want Companies To Name Names Among the information requested in the letter:
For years, major drug companies have been giving state governments and other organizations "educational grants," ostensibly to be used to promote good health and
to inform the public of treatment options that they may not have known about.
Now, two senators want drugmakers to prove that these grants are legit instructional tools - and not promotional campaigns disguised in grant garb.
On June 9, Sens. Chuck Grassley (R-IA) and Max Baucus (D-MT) sent a letter to all of the major drug companies asking for more data about their educational
grants. The letter aims to find out which drugmakers are on the up-and-up with their educational grant programs.
"I support drug companies giving back to the community through grants. However, I am concerned that some grants may be for purposes other than education," said Baucus, ranking member of the Senate Committee On Finance, which handles the oversight duties for Medicare and Medicaid.
Both senators have grave concerns about how much Medicare and Medicaid money will soon start pouring into pharmaceutical companies' pockets: Estimates have the price tag for prescriptions in 2006 hitting around $100 billion.
"We need to know how this behind-the-scenes funneling of money is influencing decision-makers; these decisions result in the government spending billions of
dollars on drugs," explained Grassley, who chairs the Senate Committee On Finance.
"Marketing practices that increase the rates at which drugs are prescribed ... are of concern because they have the potential to increase program costs and may encourage the use of newer, more expensive drugs that have not been proven superior to existing treatments," the letter reads.
Educational grants play an active role in ensuring that providers are well informed about the benefits of medications, says Jeff Trewhitt of the Pharmaceutical
Manufacturers and Research and Manufacturers of America. Trewhitt did note that each pharmaceutical company makes its own decisions as to how its grants are
determined and targeted.
Medicare Compliance & Reimbursement
- Pharmaceuticals:
Senators Want Drugmakers To Grant Them More Info
Baucus, Grassley asking questions about 'educational grants.'
For years, major drug companies have been giving state [...] - Pharmaceuticals:
Doctors Welcome Competitive Drug Demo
Oncologists most likely to feel negative effects of new program.
Some physicians are optimistic about Medicare's [...] - HOME HEALTH:
CMS Giveth, And Taketh Away, HHA Cost Report Victory
Favorable PRRB decision on therapist compensation won't last much longer.
Home health agencies that have filed [...] - Rehab:
HHA Therapy Threshold May Not Hold With New PPS
PPS tune-up will likely include big changes for therapists.
The first overhaul of the prospective payment [...] - Medicaid:
Studies Say Medicaid Shoulders Too Much Burden
Medicaid must ID high-cost benes, say researchers.
As a special, presidentially-appointed commission rolls up its [...] - DME:
Suppliers Moving Closer To Ambulation Standard
Mind the gap between NCD's effective and implementation dates.
The Centers for Medicare and Medicaid Services [...] - Medicare Modernization Act:
Undocumented-Alien Treatments Could Land Pay
EMTALA funding available until 2008.
Hospitals can receive direct payments from their states for some or [...] - Long-Term Care:
Long-Term Concerns For Medicaid Long-Term Care
Can Medicaid still fill the LTC coverage gap?
With big changes in the government's healthcare policies [...] - Physicians:
Medicare Cards Must Match Other Patient ID
Don't neglect middle names, or claim may be shunned.
Physicians in offices that doesn't always check [...] - Enforcement Watch:
DOJ Doling Out Stiff Punishment In Deceased-Px Case
PA billing at a physician's rate facing a half-century in the big house.
Submitting outpatient [...] - Hospitals:
CMS Looking To Change IPPS Billings
New medical services and technologies could bolster payments.
Hospitals should watch for a number of new [...] - Bill Watch
The following bills were introduced in the Senate:
S. 1225. A bill to expand access to [...]
